2018 Beacon Meeting Archive

Posted on December 31, 2018 by Beacon Angels

During 2018 Beacon Angels entertained new funding proposals from companies and due diligence reports, respectively, as follows :

January 9, 2018

  • Meenta which helps scientists more fully access costly and limited laboratory resources by finding, accessing and sending biological samples to idle equipment via the Cloud; and
  • Tӧst Beverages, which develops and sells uniquely delicious non-alcoholic celebratory beverages.

February 13, 2018

  • Jobletics, an on-demand temp staffing marketplace for the food service and hospitality industry, and
  • Name Net Worth, which offers an app to convert your networking activity into sales opportunities.

Members’ due diligence reports: Magurobotics, and Töst Beverages. 

March 13, 2018

  • GoPetie, a B2B & B2C mobile platform that connects pet owners to each other, to local service providers and municipalities in a social community environment, and
  • GuruSnaps, which connects business owners with professionals (Gurus) who can help them sell their business on the best terms.

Members’ due diligence reports: Töst and Jobletics.

April 10, 2018

  • Rockstep Solutions, which offers Climb, a scalable SaaS animal laboratory informatics software product that is designed in the Azure™ Cloud to leverage smart-lab technologies and utilize more elastic resources.

Due diligence update: Tӧst,

Beacon hosted funding updates by the CEOs of Pykus Therapeutics, and Spiro Technologies.

May 8, 2018

  • Zippity Cars, which offers maintenance services directly to car owners at their place of business,
  • BioTrak Therapeutics, which offers a mobile behavioral health app for the 2.4 billion people worldwide who suffer from frequently recurring tension-type headaches & migraines, and
  • ScholarJet, where students earn college scholarships and companies reach a talented pool of college students, vet candidates for internships and employment, and enhance their employer brand.

We heard an update on Meenta, a prior Beacon presenter.

June 12, 2018

  • LASO Technologies, which is selling a very waterproof Iphone case and is developing other field-use Iphone accessories; and
  • ENTERAstim, which is developing a therapeutic system to stimulate the small bowel in the human GI tract electrically and speed the return of its motility from ileus to normal.

We also heard:

  • Due diligence reports on Zippity Cars and on ScholarJet, and
  • An update from the CEO and founder of portfolio company Ecare Vault.

Finally, we conducted a full review of the health and prospects of the companies in the Beacon Angels portfolio.

July 10, 2018

  • Waec, which provides a low-cost, efficient local delivery option for consumers and stores using autonomous ground drones that politely navigate sidewalks and crosswalks, and
  • Mobile Price Card is which offers a patent-pending technology to help consumer electronics retailers improve sales by advertising on the screens of devices already on display.

September 11, 2018

  • QMedic, which offers a smart emergency help button service partnered with health insurers to support high-risk members living at home; and
  • Datarista, a platform for data providers in the third-party Sales & Marketing data industry to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua.

Member reports:

  • Beacon’s participation in any extension of the Zippity round; and
  • Update on the pending bridge round by Siamab Therapeutics.

October 9, 2018

  • Omega Trace, which is offering a product suite for brick and mortar businesses to monitor and track visitors to their premises, and
  • Weft-Tex, which has developed and is selling a proprietary breath-through crib mattress.

Member updates and due diligence: Datarista, and Zippity Cars.

November 13, 2018

  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system to diagnose antibiotic-resistant infections in hospitals; and
  • Enviro Power, which has developed the SmartWatt™ Boiler, a 95% efficient, closed-loop micro steam turbine for heating systems in homes and businesses to generate electric power on-site both as a backup and more cheaply than grid-supplied power.

Members’ due diligence reports and company updates:

  • Datarista, a platform in the third-party Sales & Marketing data industry for data providers to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua; and
  • Concrete Sensors, which is selling a system for building professionals to monitor and control the concrete curing process.

December 11, 2018

  • Invitrometrix, which has developed and is selling devices to life science research and drug discovery companies that uniquely provide continuous, real-time, quantitative monitoring of cells in culture, and
  • Walch High School Math, which automates the development and deployment of high school curricula, giving school districts a virtual curriculum department in the cloud.

Member Due Diligence:

  • Datarista, which offers a data platform for the Sales & Marketing data industry; and
  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system for the on-site diagnosis of antibiotic-resistant infections in hospitals.
Posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations, Uncategorized | Tagged , , , | Leave a comment

2022 Beacon Meeting Archive

Posted on December 13, 2022 by Beacon Angels

The eleven regular meetings of Beacon Angels in 2022 covered the following:

January 11, 2022

VeraMorph & Dyad Medical

Beacon Angels entertained the following presenters at its January 2022 meeting:

  • VeraMorph: reformulating generic drugs to be more efficacious orally and co-developing new drugs through partnerships as a means to establish a diversified, low risk portfolio of therapeutics across a wide range of disease areas;
  • Dyad Medical: developing AI-enabled clinical applications to assist cardiologists in the interpretation of medical images; and

We entertained a follow-on funding proposal from GelMEDIX, which is developing therapeutic drug-eluting gel capsules for the eye.

Members reported on current funding rounds, by Series number:

  • S96, NF2 Therapeutics, developing a curative gene replacement therapy for the deafness, loss of mobility and devastating brain tumors caused by the NF2 orphan disease, and targeted antibody-drug conjugates to treat NF2-caused meningiomas.

Members delivered due diligence reports:

  • Shoreline Biome (Zainulbhai, Doscher & Smith) developing and selling patent-protected assays for more accurate and comprehensive human microbiome testing and research;
  • Jaia Robotics (Dave Smith) developing “JaiaBots,” low cost, high speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to collect aquatic data from coastal waters up to 100m, estuaries, rivers, lakes and marshlands; and
  • Imago Rehab (Michael Pietrasiewicz, Vicky Davis), providing a virtual clinic using telerehab supplemented by a robotic glove to facilitate daily, high-repetition rehabilitation to hand-impaired stroke patients.

February 8, 2022

TopProp Fantasy Sports & Encapsulate

At the Beacon meeting held on February 8, 2022, members entertained new company funding proposals from the following:

  • TopProp Fantasy, offering a daily fantasy sports platform that simplifies DFS down to its core: single-player fantasy; and
  • Encapsulate, which is develops an automated tumor-on-a-chip system to grow patient-derived microtumors, to screen them against a variety of chemotherapeutic drugs.

Members reported on the new company funding round of NF2 Therapeutics, together with that of Cognoptix, which raised $740K of a targeted $500-$700K convertible debt round to revamp and supplement the results of its most recent clinical trials.

Members delivered due diligence reports on the following companies:

  • Dyad Medical, which is developing AI-enabled clinical applications to assist cardiologists in the interpretation of medical images;
  • Jaia Robotics, developing “JaiaBots,” low-cost, high-speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to collect aquatic data from coastal waters down to 100m, estuaries, rivers, lakes and marshlands; and
  • Imago Rehab, providing a virtual clinic using telerehab supplemented by a robotic glove to facilitate daily, high-repetition rehabilitation to hand-impaired stroke patients

March 8, 2022

Contacts411 & Connective Health

At the Beacon Angels meeting on March 8, 2022, we entertained funding proposals from the following:

  • Ryan Hess, of Contacts411, which provides contact data enhancement and updating for very small businesses; and
  • Karen Sallick, of Connective Health, providing a SAAS platform to help primary care providers deliver behavioral healthcare (diagnosis and treatment of mental health, substance abuse, and associated physical disorders).

We discussed the funding rounds of Jaia Robotics, and Imago Rehab.

We discussed due diligence as to Dyad Medical, Shoreline Biome, TopProp Fantasy, and Encapsulate.

April 12, 2022

Pointz Mobility & The Family Learning Company

Beacon Angels entertained the following presenters at its April 2022 meeting:

  • Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities; and
  • The Family Learning Company, creating literacy software that connects adult learners and their children.

We discussed the funding rounds of Jaia Robotics, and Imago Rehab.

We discussed due diligence reports as to Shoreline Biome, TopProp Fantasy, Encapsulate and Connective Health.

May 12, 2022

Bloom for All & OrderTaker Solutions

Beacon Angels members entertained funding proposals from the following new company presenters:

  • BloomForAll (Joanne Mercaldi & Team), offering teenagers a safe, inclusive and mindful health information platform powered by doctors, educators, organizations, and social influencers; and
  • OrderTaker Solutions (Amit Gathani), a Wholesale Distribution technology startup developing a mobile ordering app for field sales reps to engage in direct store delivery sales and increase sales revenues by at least 15-20%.

Members delivered a report on The New England Quarterly Summit of the Angel Capital Association held on May 4, 2022.

We heard member due diligence reports on the following:

  • Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities;
  • Encapsulate, developing automated tumor-on-a-chip systems that can grow patients’ cancer cells and test the efficacy of cancer drugs; and
  • Connective Health, disrupting behavioral health care.

June 14, 2022

Gynion, Idle Smart & Veramorph

Beacon Angels entertained the following presenters:

  • Gynion—developing MenorrxTM treatment for Heavy Menstrual Bleeding (HMB), Menorrx is a safe and effective endometrial ablation therapy that is simpler, easier to use, and costs a fraction of the available alternatives;
  • IdleSmart—offering a proprietary IoT solution for truck fleets to reduce yearly fuel costs of $10,000 per truck while increasing vehicle uptime and availability; and
  • Veramorph, which reformulates generic drugs for oral efficacy and is co-developing a diverse portfolio of new drugs with a beachhead in the oral delivery of drug treatment for metastatic breast cancer.

There followed a due diligence report on Pointz Mobility, a safety-focused mapping app that leverages crowdsourcing to help guide bike and scooter riders through pleasant, lower-stress routes in cities.

Members reported on the funding rounds of:

  • TopProp Fantasy, which has finalized the terms of its convertible note; and
  • Imago Rehab, which has accepted an extension of BA Series 99’s investment.

July 12, 2022

RT Microfluidics & Alleviate Therapy

Beacon Angels entertained the following presenters at its July meeting:

  • RT Microfluidics, which is developing a platform for saliva-based at-home diagnostics using molecular technologies; and
  • Alleviate Therapy, which develops and sells self-treatment systems for chronic injuries, combining physical and digital technologies, with an initial focus on Plantar Fasciitis.

Beacon heard an update from portfolio company CEO David Bean, of Dermal Photonics, which develops effective and widely popular optical devices for the smoothing of facial wrinkles.

Members also reviewed current funding rounds:

  • TopProp Fantasy, offering a daily fantasy sports platform that simplifies DFS down to its core: single-player fantasy; and
  • Imago Rehab, offering remote hand therapy and rehabilitation to medical patients via a Web-linked robotic glove.

September 13, 2022

Skope & Passiva

Beacon Angels entertained the following presenters at its September 2022 meeting:

  • Skope, offering a wall-mounted point-of-care bracket for the convenient and rapid disinfecting of the stethoscopes of medical service providers;
  • Passiva PLT, developing the delivery by nanoparticle of passive phototherapy to transform the growth, healing and preventative capabilities of living things as an additive to everyday products; and
  • (as a followup to a previous presentation) OrderTaker Solutions, a wholesale distribution technology startup developing a mobile ordering app for field sales reps to conduct direct store delivery sales to increase revenues by 15% or more.

Members discussed new funding rounds by the following, by Series number:

  • S102 GelMEDIX developing gel-formulated drug delivery for the eye; and
  • S103 Dermal Photonics, funding the sales and marketing of its new laser device.

October 11, 2022

FIND Neuro & QSM Diagnostics

Beacon Angels entertained the following presenters at its October meeting:

  • FIND Neuro–employing proprietary neuronal dynamic algorithms to guide neurosurgeons in the treatment of Drug-Resistant Epilepsy;
  • QSM Diagnostics–selling diagnostic mail-in kits and instruments to veterinarians to enable pet owners to collect samples and obtain diagnostic test results more quickly;
  • In a follow-up, portfolio company NF2 Therapeutics reported on its clinical progress on both the ADC and genetic therapy fronts against its rare NF2 disease target; and
  • In another follow-up, Lenoss Medical reported on its resumed progress toward approval of its device for surgeons to deliver internal support to crushed or weakened spinal vertebrae.

Members reported, by Series number, on the follow-on funding rounds of:

  • S104 Diesel Labs, which continues building its platform for providing marketing feedback to streaming companies; and
  • S105 IdleSmart, which offers intelligent truck idling management to save diesel fuel costs.

Members also reported on companies now in due diligence, Skope, Alleviate and Veramorph.

November 8, 2022

StageConnect & Mimosa

Beacon Angels entertained the following presenters at its November 2022 meeting:

  • StageConnect (Cole Morgan), a two-way one-to-many video solution for live events that lets speakers see and interact with the faces of all live stream attendees in real-time; and
  • Mimosa (possible, demonstration basis)(Karen Cross), developing subcutaneous skin imaging for wound early detection & treatment.
  • For its follow-on round, Hilltop Biosciences, delivered an update on its developing and selling of new forms of wound care for veterinary use.

Members reported on the following companies now in due diligence: 

  • Skope, developing handy point-of-care sterilization for stethoscopes;
  • Veramorph, reformulating generic drugs for oral efficacy with a bridgehead in the oral delivery of a standard therapy for metastatic breast cancer;
  • QSM Diagnostics, selling diagnostic mail-in kits and instruments to veterinarians to enable pet owners to obtain diagnostic testing results faster; and
  • MicroDX, developing a platform for saliva-based at-home diagnostics using molecular tech.
  • Alleviate.

December 13th, 2022

Everyday Life & Stratagen Bio

  • Everyday Life, in a repeat presentation, described how it is seizing the $40 billion opportunity to make life insurance accessible and affordable for middle-income families; and
  • Stratagen Bio, which is enabling oxygen-guided personalized cancer therapies using proprietary innovations in materials science and MRI image acquisition and processing.
  • In a portfolio company update, AOA Diagnostics described how it is bringing to market the first accurate early-stage non-invasive ovarian cancer diagnostic test; and in another,
  • NF2 Therapeutics reported on its clinical success in developing orphan-disease treatments for the NF2 disease both on the ADC and the gene-therapy fronts. 

Members reported on current funding rounds, by Series number.

  • S86B Lenoss Medical;
  • S96B NF2 Therapeutics;
  • S106 Xeno; and
  • S108 Hilltop Biosciences.

Members reported on the following companies now in due diligence:

  • Skope, developing handy, point-of-care sterilization for stethoscopes;
  • Veramorph, reformulating generic drugs for oral efficacy;
  • QSM Diagnostics, offering diagnostic mail-in kits and instruments to veterinarians to enable pet owners to obtain diagnostic testing results faster;
  • MicroDX, developing a platform for saliva-based at-home diagnostics and
  • StageConnect, which is developing a platform to support large, corporate-wide remote meetings.
Posted in Angel News, Beacon Angels Events, Beacon Angels Exits, Beacon Events, Boston angel investing, Funding Presentations, Uncategorized | Tagged , , , , | Leave a comment

2021 Beacon Meeting Archive

Posted on December 14, 2021 by Beacon Angels

Beacon Angels covered the following topics in its eleven regular meetings of 2021:

January 12, 2021

Did U Remember To & General Prognostics

Beacon Angels members heard the following new company presenters at its January meeting:

  • Did U Remember To; which has develped a combined Bluetooth Low Energy Beacon and mobile app product for providing JIT reminders, notices and alerts to consumers and businesses throughout the world, and
  • General Prognostics, which is developing a continuous blood biomarker monitoring platform to identify significant patient status changes, and to notify physician and patient, thus enabling therapy changes to avoid hospital readmissions.

We heard updates on the new funding rounds of:

  • Cognoptix bridge debt;
  • First Light Diagnostics, and
  • RevBio (f/k/a Launchpad Medical).

February 9, 2021

ThoughtData & Everyday Life

Beacon Angels entertained the following new funding proposals at its February meeting:  

  • ThoughtData, helping enterprise businesses to detect and resolve network, application and infrastructure performance issues more effectively with a better end-user experience, and
  • Everyday Life, disrupting life insurance for everyday people.

Members reported on companies in due diligence consisting of General Prognostics.

We heard updates on the funding rounds of:

  • Cognoptix bridge debt, and
  • RevBio (f/k/a Launchpad Medical), and
  • Lenoss Medical.

March 9, 2021

AOA Diagnostics & AIDX

Beacon heard the following new funding proposals at its March meeting:

  • AOA Diagnostics developing a new and more accurate diagnostic method for ovarian cancer, and
  • AIDX providing digital pooling worldwide, and initially in East Africa, whereby people can contribute regularly to a shared pot and agree upon the rules for how funds will be used.

April 13, 2021

Carmyn & Yarn Corporation

At its April meeting, Beacon Angels entertained the following new funding proposals:  

  • Carmyn, offering a Gas Station on Wheels–saving shoppers time by refueling their cars in the store parking lot; and
  • Yarn Corporation, developing Driftspace, the only “no code” app aimed at VR video content creators with a non-trival WYSIWYG editor and a real-time Web dashboard enabling copy and paste from email into headset content.

Members reported on companies in due diligence consisting of General Prognostics, Everyday Life and AOA Diagnostics.

We heard updates on the funding rounds of GelMEDIX and RevBio, plus an update on the new funding round of Xeno Biosciences delivered by CEO Dr. David Beno.

May 11, 2021

Octagon Therapeutics & Genomic Expressions

At its May meeting, Beacon Angels members entertained the following presenters:  

  • Octagon Therapeutics, which is developing precision immunomodulators for chronic autoimmune diseasethat specifically target immune dysregulation; and
  • Genomic Expressions, which offers OneRNA,® a disease agnostic exponentially scalable RNA analysis platform to detect disease, monitor health and design next-generation cures.

Members reported on companies in due diligence consisting of: 

  • Yarn Corporation; and
  • AOA Diagnostics.

We heard updates on the funding rounds of Cognoptix, GelMEDIX, RevBio and Xeno Biosciences.

June 8, 2021

TIKI, AmplifiDx & Hilltop BioSciences

At its June meeting, Beacon Angels members entertained funding proposals from the following presenters:

  • TIKI, building software to accord ownership to social media users over the data collected on them consisting of seeing it, controlling how it is used, when it is sold, and how to get paid for its sale; and
  • AmplifiDx, offering its Molecular Point-of-Care biotechnology platform in the development of the DX 1000 System for infectious disease testing at the point of care; and
  • Hilltop BioSciences, a veterinary biotech offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis.

Members reported on Octagon Therapeutics in due diligence.

We heard updates on the funding rounds of AOA Dx, GelMEDIX; Cognoptix, RevBio, and Xeno Biosciences.

July 13, 2021

Intraday & Soul Being

At our meeting on July 13, 2021 the members of Beacon Angels entertained new funding proposals from the following presenters:

  • Intraday, developing AI tools in the financial technology field to enable companies to forecast and deploy cash efficiently and more productively; and
  • Soul Being, a healthcare services platform to help users navigate integrative medicine alternatives that improve their health while saving money for their employers and health plans.

CEO Adam Honig also delivered an update on Spiro Technologies.

Members reported on companies in due diligence consisting of: 

  • AmplifiDx, offering a Molecular Point-of-Care biotechnology platform via the DX 1000 System for accurate, convenient, and affordable infectious disease testing;
  • Hilltop BioSciences, a veterinary biotech company offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis; and
  • TIKI, building software for users to own the data collected on them by social media companies consisting whereby they can see their data, control when and how it is sold and used, and get paid for its sale.

We heard updates on the funding rounds of:

  • Cognoptix,RevBio, and
  • Xeno Biosciences.

September 14, 2021

Phimentum, Reeske & Dermal Photonics

At its meeting on the morning of September 14, 2021, Beacon Angels members entertained funding proposals from:

  • Phimentum, which supplies a novel form of therapeutic braces to general dentists, enabling them to generate high profits while lowering patient costs and geographic barriers; and
  • Reeske, offering embeddable insurance technology for financial institutions to white-label life and disability insurance products to consumers, and
  • Dermal Photonics, offering a patented device for home laser self-treatments superior to those of a professional dermatologist at a fraction of the cost.

Members reviewed due diligence reports on companies consisting of:

  • AmplifiDx, offering a Molecular Point-of-Care biotechnology platform via the DX 1000 System for accurate, convenient, and affordable infectious disease testing;
  • Hilltop BioSciences, a veterinary biotech offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis; and
  • Intraday, developing AI tools in the financial technology field to enable companies to forecast and deploy cash efficiently and more productively.

Members heard an update on the upcoming funding round of AOA Dx, as well as portfolio company updates.

October 12, 2021

Embrace Prevention Care & NF2 Therapeutics

At its meeting on the morning of Tuesday, October 12, 2021, Beacon Angels members entertained new company funding proposals as follows:

  • Embrace Prevention Care (speaking in person, David Dlesk, CEO), which provides Personal Prevention Care, an integrated suite of geriatric telehealth and pharmacy services designed to prevent hospitalizations and lower costs of care for older adults with heart failure and other chronic conditions; and
  • NF2 Therapeutics (from en route to Montreal,  Michael Wootton, CEO), a biotechnology company developing gene replacement therapy to prevent deafness, loss of mobility and devastating brain tumors from NF2, and a targeted antibody-drug conjugate to treat meningiomas from NF2 and sporadic meningiomas. Both therapies are eligible for the FDA’s Orphan Drug Designation.

Members presented their due diligence report on Intraday, developing AI tools in the financial technology field to enable companies to forecast and deploy cash efficiently and more productive.

CEO Ron Murphy presented in person on the extension of Theromics’ fundraising round.

We heard updates on Beacon’s new portfolio companies:

  • AmplifiDx, offering a Molecular Point-of-Care biotechnology platform via the DX 1000 System for accurate, convenient, and affordable infectious disease testing; and
  • Hilltop BioSciences, a veterinary biotech company offering novel therapies for inflammatory diseases such as equine asthma and canine osteoarthritis.

November 9, 2021

Lightwater Biosciences & Shoreline Biome

At its monthly breakfast meeting on November 9, 2021, Beacon members met in person and remotely, where we heard new company funding proposals as follows:

  • Lightwater Biosciences (speaking in person: CEO Soo-Young Kang & Bill McCullen of Launch Capital) offering biweekly subscriptions delivering freshly made, preservative- and irritant-free, perishable, short-use cycle, single-application, skincare products; and
  • Shoreline Biome (speaking in person: Paul Denslow, CEO & CSO, Mark Driscoll) developing and selling patent-protected assays for human microbiome testing and research.

Beacon members presented due diligence reports on the following companies:

  • Dermal Photonics, offering a patented device for home laser self-treatments superior to those of a professional dermatologist at a fraction of the cost;
  • Embrace Prevention Care, which provides Personal Prevention Care, an integrated suite of geriatric telehealth and pharmacy services designed to prevent hospitalizations and lower costs of care for older adults with heart failure and other chronic conditions; and
  • NF2 Therapeutics, developing gene replacement therapy to prevent deafness, loss of mobility and devastating brain tumors from NF2, and a targeted antibody-drug conjugate to treat meningiomas from NF2, with both therapies eligible for the FDA’s Orphan Drug Designation.

December 14, 2021

Jaia Robotics & Imago Rehab

In another hybrid meeting held on December 14, 2021, Beacon Angels members heard the following new company funding proposals:

  • Jaia Robotics, developing “JaiaBots,” low-cost, high-speed, micro-sized autonomous aquatic robots that work in pods of up to 20 to collect aquatic data from coastal waters down to 100m, estuaries, rivers, lakes and marshlands; and
  • Imago Rehab, providing a virtual clinic using telerehab supplemented by a robotic glove to facilitate daily, high-repetition rehabilitation by hand-impaired stroke patients. 

We heard updates on new and follow-on funding rounds as follows:

  • Theromics‘ Series Seed extension round; and
  • Dermal Photonics‘ convertible note with 20% warrant coverage.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings | Tagged , , | Leave a comment

2020 Beacon Meeting Archive

Posted on December 31, 2020 by Beacon Angels

The following summarizes the 11 regular Beacon Angels meetings during 2020 as follows:

January 14, 2020

New funding proposals:

  • Theromics, which is developing HeatSYNC™ a new medical device technology to optimize thermal ablation (IGTA) of solid tumors or soft tissue; and
  • Testive, which uses machine learning to deliver test prep at a lower cost and at higher margins.

Members presented due diligence reports on Jetcool Technologies, Native Voice, and Navigation Science.

February 11, 2020

  • Wabbi; which is developing a platform to provide continuity of information to make security scalable between software development pipelines, so teams no longer have to choose between speed and security; and
  • IndustrialML, which is an enterprise software company that collects, cleans, and curates factory sensor and enterprise IT data, enabling industrial customers to optimize factory productivity using its proprietary machine-learning SaaS platform.

We reviewed and discuss company updates including:

  • Exit of The Search Agency,
  • Exit of Concrete Sensors, and
  • Funding follow-on rounds including of Launchpad Medical, and Xeno.

Members reported on companies in due diligence consisting of:

  • Theromics, and
  • Testive.

March 10, 2020

  • Enrich Therapeutics, which is developing a LCD-guided cell-isolation platform to enable life science research at the single-cell level; and
  • Obsidian Advanced Manufacturing, which offers a breakthrough method of printing micron-scale sensors, electromagnetics structures and radio-frequency devices directly on high-value assets.

Review and discussion of company updates including:

  • The exit of Concrete Sensors,
  • Funding a follow-on round of Xeno,
  • Funding a new round into Theromics, and
  • Completing the follow-on funding of Launchpad Medical.

April 14, 2020

Funding proposals from new companies:

  • Zeptive, which is developing a system of IOT sensors to be distributed in campuses to enable school administrators to detect banned student vaping activities; and
  • Diesel Labs, which is developing a platform to identify and analyze audience preferences as to streaming television content for media and marketing firms and companies.

Member due diligence reports:

  • Wabbi, and
  • Enrich Therapeutics.

The meeting was conducted virtually via Google Groups due to statewide efforts to retard the spread of the novel coronavirus: “15 days to stop the spread.”

May 12, 2020

Funding proposals from new companies:

  • Matthew Palmer proposed funding Orthofundamentals, which is developing an app and disposable procedural kits to simplify and help improve orthopedic care at ambulatory surgery centers (ASCs), and
  • CEO Jeff Behrens, biomolecular engineer Nasim Annabi & eye surgeon Reza Dana delivered a proposal for GelMEDIX, a new start-up to develop a light-activated biomaterial with unique properties of tissue adhesion, tunable drug elution, and biocompatibility.

Members due diligence reports on:

  • Diesel Labs, and
  • Enrich Therapeutics, and

Returning CEO Susanne Wilke gave an update on Cognoptix.

June 9, 2020

At its third virtual meeting in a row due to the Wuhan virus panic, members heard presentations from:

  • RevMedica, whose CEO Thomas Wenchell proposed funding for, which is developing a reusable robotic-assist system for handheld laparoscopic surgery, and
  • Ori Noked, Founder and CEO of ORI Imaging, which is developing an optical imaging device for early diagnosis, screening and monitoring of deep tissue pathological conditions such as pressure injuries, post-traumatic brain injury inflammation, and potentially, skin cancers.

Members heard due diligence reports on:

  • Diesel Labs
  • Enrich Therapeutics, and
  • GelMEDIX,

and heard updates on follow-on funding rounds for:

  • Theromics,
  • Cognoptix and
  • First Light Diagnostics.

July 14, 2020

Company funding proposals:

  • Ocular Technologies, which is developing a machine-learning telemedicine device platform to enable ophthalmologists to diagnose eye problems remotely and prevent blindness in up to 220 million new, remotely located patients per year; and
  • New View Surgical, whose patented, high-definition VisionPort imaging technology combines four devices–scope, camera, light source, trocar–into one easy-to-use and cost-effective device to assist surgeons in performing laparoscopic procedures.

A Member gave a due diligence report for RevMedica.

We heard updates on new or renewed funding rounds for:

  • Diesel Labs,
  • Theromics, and
  • GelMEDIX.

September 15, 2020

The new funding proposal was for Vincere Biosciences, which is developing small molecule therapeutics targeting mitochondrial quality control to cure age-related and neurodegenerative diseases.

Member due diligence reports:

  • Ocular Technologies, and
  • RevMedica.

We heard updates on new or renewed funding rounds for:

  • Diesel Labs,
  • First Light Diagnostics,
  • Theromics, and
  • GelMEDIX.

October 13, 2020

New funding proposals:  

  • 40GRID (f/k/a SOLVD), which is developing and marketing business-automation software for field-services companies; and
  • Cloud9 Online offering a “Medical Grade,” white-labeled meditation app, designed by healthcare & insurance professionals to improve chronic pain management, reduce opioids & increase patient compliance.

Member due diligence reports on: 

  • Ocular Technologies, and
  • Vincere Biosciences.

We heard updates on the new funding rounds of:

  • First Light Diagnostics (by CEO David MacDonald),
  • Datarista, and
  • RevBio (f/k/a Launchpad Medical).

November 10, 2020

New funding proposals on:

  • Amplify, a US-based additive manufacturing company specializing in the design, engineering, and manufacturing of 3D metal-printed orthopedic implants; and
  • Fit7, which is offering a patented, portable, compact, rugged mountable exercise assembly for strength & flexibility training that is lightweight and functionally designed to build total-body strength, muscular endurance, help gain flexibility, balance, boost mood, and increase energy.

Due diligence reports on:

  • 40GRID,
  • Ocular Technologies, and
  • Vincere Biosciences.

New funding rounds updates on:

  • the Cognoptix convertible note, and
  • RevBio (f/k/a Launchpad Medical).

December 9, 2020

New company presentations from:

  • Lenoss Medical, which offers a natural, biological implant solution for spinal fractures to be supplemented with new bone and for the fracture to naturally heal while eliminating all the associated risk of the current standard of care of injecting a synthetic epoxy cement; and
  • Torigen Pharmaceuticals, which is developing affordable anti-cancer biologics for dogs and cats.

Members reported on companies in due diligence consisting of: 

  • Ocular Technologies, and
  • Amplify

We heard updates on the new funding rounds of:

  • Cognoptix convertible debt;
  • First Light Diagnostics, and
  • RevBio (f/k/a Launchpad Medical).

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings, Private Equity | Leave a comment

2019 Beacon Meeting Archive

Posted on December 31, 2019 by Beacon Angels

At its regularly scheduled meetings during 2019 Beacon Angels entertained new funding proposals from companies and due diligence reports, respectively, as follows :

  • Neurohydrate which offers a nutritional supplement to help migraine sufferers mitigate the gastrointestinal side effects of treatments, and
  • Theromics, which offers a platform for surgeons and oncologists to thermally ablate cancerous tumors, potentially cutting recurrence from an average of 30% to zero.

Due diligence: Walch High School Math.

February 12, 2019

  • WEVO, which enables marketers to evaluate and enhance digital experiences without the need for live traffic, disrupting the traditional market research and AB testing tools. and
  • Xeno Biosciences, which is developing a treatment for obesity that mimics gastric bypass surgery with an enteric-coated pill composed of components that have been shown to be safe in man. It induces the same microbiome changes caused by the surgery resulting in weight loss.

We also entertained a presentation by The Capital Network.

  • Cricduel, a fantasy cricket app (i.e. Draftkings, but for cricket) where users create fantasy cricket teams and compete with other users for cash prizes; and 
  • Canary, offering the services of an Airbnb, but for performing artists (bands and musicians) and venues such as restaurants and bars. 
  • Hilltop Biosciences, which develops and sells therapies for wound healing to large animal veterinarians; and 
    Shareity, which offers a patented social engagement platform to enable brands to create photo and video challenges whereby brands can donate money to causes as users complete the challenges. 

Due diligence: Xeno Biosciences and Canary.

Beacon portfolio company Cognoptix delivered an update on its upcoming bridge round to a larger financing, whereby the valuation is hoped to represent at least a 10X increase over Beacon’s original investment over 10 years ago.

May 14, 2019

  • Southie Autonomy, which is developing software to program robotic arms on the fly; and
  • CloudKPI, which offers predictive analytics for SaaS businesses to use business data to identify what delivers positive or negative outcomes.  

Due diligence report: Shareity.

June 11, 2019

  • U-Chu Biosensors, which is developing real-time oral health sensors for critical care; and
  • KingsCrowd, which is offering an analytics and ratings solution for online private equity markets.  

Enviro Power, a past presenter offering a micro-power generation solution, gave Beacon an update on new progress and on its current funding round.

July 9, 2019

  • Eden GeoTech, which is developing a new means of petroleum reservoir extraction using electrical stimulation in lieu of hydraulic fracturing; and 
  • Mollify, which use game techniques to incent smartphone users to create and upload their own video advertisements for client advertisers.

Due diligence reports on:

  • Enviropower which is developing a furnace-based system for point-source power generation, and
  • KingsCrowd, which seeks to become the Morningstar of the private equity markets.
  • PartRunner, which provides on-demand deliveries for trades, construction and service businesses through (1) Web and mobile apps where customers can request, track and manage deliveries and (2) a mobile app that allows drivers to match with deliveries, see routes and manage their profile business model; and 
  • Revital Therapeutics, which is developing improved, skin-substitutes to serve the $1 billion diabetic wound treatment market.

October 8, 2019

  • FastClose, which offers an on-line platform on which to close real estate sales and purchases; and 
  • ZipperAgent, offers an AI-based mobile and conversational smart assistant for real estate agents and brokers.

Due diligence: KingsCrowd.

We also heard progress reports about follow-on rounds by Datarista, Cognoptix and First Light.

We also considered follow-on funding proposals from Cognoptix and First Light Diagnostics.

November 12, 2019

  • Uneva Health, which is developing a medical device to improve asthma inhaler usage and compliance; and 
  • JETCOOL Technologies, which is developing integrated cooling solutions for the most power-dense electronics in defense, e-sports and AI processing.

December 10th, 2019

  • Native Voice, which is developing an open operating system to enable manufacturers of smart headphones, a/k/a “hearables,” to add voice applications to any device; and
  • Navigation Science, which is developing Image-guided Video-Assisted Thoracoscopic Surgery (iVATS™) technology for the minimally invasive identification of early-stage tumors and their margins, and their more precise removal from the lungs and other soft tissues.

Due diligence: Uneva Health, and Jetcool Technologies.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings, Private Equity, Uncategorized | Tagged , , | Leave a comment

Massachusetts Rated No. 1 for Innovation

Posted on June 4, 2019 by Beacon Angels

WalletHub recently listed Massachusetts as first among all 50 of the United States for its potential to foster innovation, as well for having the number three healthiest economy overall so far in 2019.

Beacon Angels is pleased to be a contributor to that potential by continuing to invest in new startup companies based in Massachusetts and throughout New England and through its ongoing support of the many New England-headquartered companies in its portfolio.

 

Posted in Angel News, Boston angel investing | Tagged | Leave a comment

Beacon Angels 2017 Meeting Archive

Posted on December 31, 2017 by Beacon Angels

December 12, 2017

New funding presentations:

  • PrettyInstant, the world’s first managed marketplace for professional photography, saving clients time, money, and aggravation associated with hiring contract photographers; and
  • com, which is developing a marketplace to improve the used textbook-buying experience.

Member due diligence report: Magurobotics.

November 14, 2017

New funding presentations:

  • Labby, which has developed and sells a food and beverage testing device, to be used on-the-go for counterfeit detection, measurement and quality control in beer and wine production and sales; and
  • Magurobotics, which has developed and sells a lure device potentially to revolutionize the sport-fishing and bait-fishing industries.

Members’ due diligence update:

  • SNO Dietary Management.

October 10, 2017

New funding presentations:

  • Simplified Nutrition Online Solutions, which develops and markets dietary management tracking software to eldercare institutions, the US military, correctional facilities, food distributors and manufacturers; and
  • DJ Microlaminates, a materials science company seeking to market thick dry film laminate sheets and rolls for wafer fabrication processes, sensors, MEMS, microfluidics and medical and consumer devices.

Members delivered due diligence updates on:

  • Pykus Therapeutics and
  • Alps & Meters,

Plus a funding update on VetX.

September 12, 2017

New funding presentations:

  • Alps & Meters, a luxury sportswear brand powered by a home try-on model of B2C service and distribution; and
  • Crowd Comfort, a revenue generating company self-described as “Waze for buildings. We crowd-source building data (comfort, maintenance, safety, etc.) from occupants to help organizations operate more efficiently.”

Members’ due diligence reports: Pykus Therapeutics and Patheer.

August 19, 2017

garden-party-image

Beacon enjoyed its 2017 Summer Garden Party on Saturday evening, August 19th.

July 11, 2017

New funding presentations:

  • Thinking Chat employs artificial intelligence techniques to provide an improved chat agent to improve Web site lead capture by 30% or more using consistently effective dialogs 24-hhours per day.
  • Spiro Technologies uses self-writing customer relationship management software to increase sales effectiveness. Spiro aims for a CRM so intelligent that it updates itself automatically as a salesman works, and provides users with alerts to drive sales.

Member due diligence reports:

  • Pykus Therapeutics,
  • Patheer, and
  • VetX, and
  • DoneGood.

Beacon’s upcoming get together will be its Summer Garden Party on the evening of Saturday, August 19th.

June 13, 2017

Funding Presenters:

  • Nutrimedy, led by Edwin Rivera, which is developing a novel telehealth platform that transforms disease prevention and management by matching people with Registered Dietitians; and
  • DoneGood, led by Cullen Schwarz, which offers a browser extension and mobile app to help consumers to find ethically-sourced environmentally-friendly goods produced by social enterprises.

Beacon members also presented and reviewed due diligence reports on:

  • Pykus Therapeutics,
  • Patheer,
  • Frontlane,
  • VetX, and
  • NextShift Robotics.

The CEO of Siamab Therapeutics also presented an update.

May 9, 2017

Presenters were:

  • Prapela, led by John Konsin, integrates breakthrough technology into products to help babies relax, breathe and sleep; and
  • NextShift Robotics, led by Mary Ellen Sparrow, which is developing an e-commerce order fulfillment system whereby robots communicate with each other, and work more efficiently with human ‘pickers,’ enabling 3X to 8X efficiency improvements.

Beacon members also presented and review due diligence reports:

  • Pykus Therapeutics,
  • Unite GPS,
  • Patheer,
  • Frontlane &
  • VetX.

April 11, 2017

Funding Presentations:

  • FrontLane offers the Braking Bar,™ a patent pending, wireless, battery powered Adaptive Brake Light that can be added to any vehicle to help prevent the most frequent type of car accidents: rear-end collisions; and
  • VetX, which offers a communications and analytics platform for veterinary clinics and pet owners, with an initial focus on extending clinics’ triage services after-hours and on weekends.

Members’ due diligence reports:

  • Pykus Therapeutics,
  • UniteGPS,
  • QSM Diagnostics, and
  • RacerX.

March 14th, 2017

Funding Presentations:

  • Green Pinata, which sells subscriptions for high-quality, wooden toys to delight children, save parents money and reduce clutter; and
  • Patheer, which offers an enterprise talent development platform for employers to retain and grow talent while empowering employees to drive their own careers.

Member due diligence reports and updates on recent presenters:

  • Pykus Therapeutics,
  • UniteGPS,
  • MyBlend,
  • QSM Diagnostics &
  • RacerX.

February 14th, 2017

Funding Presentations:

  • Pykus Therapeutics, which is developing a dissolvable intraocular device to make retinal surgery less painful and more successful; and
  • UniteGPS, which develops software tools related to location. Their first product is being sold to school districts nationwide and is called Crosswalk.

Member due diligence reports and update: My Blend

Portfolio company CEO update: IQuartic.

January 10, 2017

Funding Presentations:

  • My Blend, creating new ways for fashion and lifestyle brands to better engage with consumers by de-cluttering their e-mail inboxes, opening conduits to the social digital lives of women in the age 25-40 demographic; and
  • The Wardrobe Essentialist, launching a two-sided menswear marketplace employing unique multi-brand data and machine learning to proffer personalized merchant recommendations, leading to more orders, lower return rates, and a superior return on Ad Spend.

We discussed our new investment in Ecare Vault, and heard diligence reports concerning QSM Diagnostics and RacerX.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings, Private Equity, Uncategorized | Leave a comment

Beacon Angels 2016 Meeting Archive

Posted on December 31, 2016 by Beacon Angels

December 13, 2016

Funding Presenters:

  • 3d Fortify, a materials 3D printing company that uses patented magnetic alignment technology to create highly complex carbon fiber composites; and
  • Flaskworks, which is developing modular, closed and disposable systems for the manufacture of dendritic cells and stimulation and expansion of T cells for the rapidly growing immuno-oncology and dendritic cell-based vaccines markets.

We also considered due diligence reports or updates on

  • Kalion,
  • eCare Vault,
  • RacerX and
  • QSM Diagnostics.

November 8, 2016

Presenters to the meeting were:

  • eCare Vault, which is developing a social network for parents of children with developmental needs to share and coordinate with health and education team members; and
  • Kalion, an industrial biotech company that will use traditional, green, fermentation technology to produce high-value chemicals at a substantially lower cost and higher purity than current methods, with a beachhead in the supply of glucaric acid, a key ingredient of Ritalin and other drugs.

Portfolio company Affectly provided a member-investors’ update.

Due diligence committees discussed QSM Diagnostics and RacerX.

October 11, 2016

Our meeting featured funding presentations by:

  • RacerX, which is paid by consumer product manufacturers to facilitate consumer product registrations with a mobile app, facilitating their relationship marketing; and
  • Eversound, which will shortly launch targeted sales of its listening enhancement devices for seniors.

We also reviewed and discussed due diligence reports concerning:

  • QSM Diagnostics, and.
  • WhisperSom.

September 13, 2016

Funding Presenters:

  • WhisperSOM, which is developing a lightweight, wearable device that works with your smart phone to interrupt sleep apnea and snoring, and
  • Cre8MDI, which is developing a medical device for the early prediction of cardiovascular disease by primary assessment of arterial stiffness by pulse wave velocity.

We also discussed due diligence reports concerning:

  • Dookans
  • XCube R&D, and
  • QSM Diagnostics.

And we discussed our just completed initial round investment in Orange Photonics.

August 14, 2016

The Beacon Angels 2016 garden party was held at the Swiggarts’ home August 14th, at which the Pat Gaulin Trio performed.

July 12, 2016

Presenters were:

  • QSM Diagnostics, which is developing a diagnostic instrument sensor to identify and monitor bacterial infections in wounds, and
  • Polis, which offers a door-knocking app and data dashboard to assist companies and political campaigns to manage and improve their field operations.

We conduct due diligence reviews of:

  • Dookans,
  • Gadfly Legal,
  • Launchpad Medical,
  • XCube R&D &
  • Orange Photonics.

June 14, 2016

The meeting featured presentations for funding by:

  • XCube R&D, which is deploying big data management systems, originally developed for the aerial drone, to help automobile companies develop, test and safety check autonomous driving systems; and
  • Orange Photonics, which is deploying the “Lightlab” laboratory grade portable analysis platforms to deliver potency analysis, of the four major cannabinoids, on-site to marijuana dealers.

The members also discussed portfolio updates for Concrete Sensors and Iquartic. They evaluated due diligence results for Dookans, Gadfly Legal, Or-Genix, Launchpad Medical and Loto Lighting.

May 10th, 2016

Presenters were:

  • Loto Lighting, which designs and sells motorized controllable display lighting, and
  • PSM Clean Energy, which simplifies financing and investing in solar projects.

Members also presented and considered due diligence reports on five pending recent presenters now under consideration.

April 12, 2016

Presenters  included:

  • Or-Genix Therapeutics, which is developing and out-licensing proprietary science based topical products to help prevent and treat hormonally aging skin and hair in women aged 40+; and
  • Launchpad Medical, which is developing and commercializing Tetranite,™ a proprietary adhesive that supports and integrates with the body’s self-repair mechanisms to help regrow bone and permanently stabilize metal hardware—initially for dental implants.

Both companies were accepted for Due Diligence.

Members delivered due diligence reports on Dookans, Gadfly Legal, and IQuartic.

March 8, 2016

Funding Presenters:

  • Gadfly Legal, which offers a leasing negotiation and management system to in house counsel and commercial leasing managers; and
  • Antera Therapeutics, which is developing the only therapy to prevent infants from developing peanut allergies.

Portfolio company Concrete Sensors, which sells a system to builders to monitor and improve the curing of concrete in commercial projects, provided an update.

February 9, 2016

Funding Presenters:

  • Medical Surface develops advanced coatings for medical devices using a proprietary single step technology. Their surfaces are designed to make biosensors work better and last longer in the body.
  • iQuartic is developing a data technology to help large health insurers and health care providers evaluate up to 40% more of the risk factors of a given population, and thereby estimate risk and costs more quickly and reliably than existing methods.

Members delivered due diligence reports on Building Conversation, Concrete Sensors, and Dookans.

January 12, 2016

Presenters were:

  • Metacomb, developer and purveyor of structural paneling and countertops fabricated from corrugated cardboard for use by architects and designers; and
  • Dookans, purveyor of ‘What the Trucks’ app enabling mostly lunchtime customers to identify, locate and purchase meals from food trucks.

Members delivered due diligence reports on Atanse, Building Conversation and Concrete Sensors.

Posted in Past Beacon Meetings | Tagged , | Leave a comment

Summer Garden Party

Posted on August 14, 2016 by Angel Treaty

garden-party-image

Beacon Angels threw a garden party the evening of August 14th at the Swiggarts’ home. Hosts grilled beef tenderloin, hot dogs and asparagus, while guests delivered a Cornucopaeia of side dishes and desserts. The Pat Gaulin Trio made a special appearance, performing jazz classics with verve and creativity, including ‘Straight, No Chaser,’ ‘Meet the Flintstones,’ and ‘Satin Doll.’ A wonderful time was had.

Posted in Beacon Angels Events | Leave a comment

Beacon Angels 2015 Meeting Archive

Posted on December 31, 2015 by Angel Treaty

December 8, 2015

Funding Presenters:

  • Qleek, which has developed, markets and sells an aesthetically pleasing music player; and
  • Clinical Research IO, which captures research data directly on tablets and in the cloud for greater accuracy, and affording drug companies substantial savings in clinical trial audit costs.

Due diligence reports: PanTher and Building Conversation.

November 10th, 2015

Funding Presenters:

 

  • PanTher Therapeutics, which is developing drug-eluting devices to deliver chemo drugs directly to hard tumors; and
  • Apptient, which is developing a system to enable advertisers to reach users of free mobile apps with targeted ads.

Siamab Therapeutics, a Beacon portfolio company and Building Conversation, currently in due diligence, also presented updates.

Oct. 13, 2015

Funding Presenters:

  • Constant Therapy, of Newton, Mass., Veera Anantha presenting, develops tools for personalized and 24×7 brain rehabilitation to patients via iPads & software tools to providers for evidence based care.
  • Brendan Dowdall, CEO, described how the phone-based system of Concrete Sensors, of Boston, Mass., enables construction management professionals efficiently to receive, monitor and analyze real time data for the drying and curing of concrete, a matter of key time sensitivity and importance for major construction projects.

Sept. 8, 2015

Funding Presenters:

  • TelePro Health(Medical Services), which provides online video to integrate remote doctors’ visits and monitoring, claims processing, eprescriptions, medical records, wearable and remote monitoring devices and real-time health app data; and
  • Atanse(Medical Devices), which develops neurosurgical instruments that enable biotechnologycompanies to deliver therapeutics in the brain with greater precision and reduced trauma.

July 7, 2015

Funding Presenters:

  • RumiSpice, which was founded by US Army Afghanistan war veterans who have established sourcing and distribution channels for the worlds most expensive spice; and
  • CrowdComfort, which offers a crowd sourcing platform for the management of commercial building facilities. Building occupants report site-specific facilities issues via smartphone.

June 2, 2015

Funding Presenters:

  • Building Conversation, Terrence Masson, CEO, has developed a subscription based app to allow architectural firms, building firms, contractors, developers and other persons involved in building and real estate development to view an augmented reality image of prospective architectural project; and
  • Oikos Software, which seeks to provide cloud based accounting software to firms of all sizes.

April 14, 2015

Funding Presenters:

  • BeTH which develops novel, human-device interfaces to improve comfort, mobility, and the health of patients, and has, most recently developed a dynamic liner that continually adjusts the fit of prosthetic devices to ease the wearer’s comfort and mobility; and
  • Treppen Technologies, which offers a decision compliance and support system for corporate governance.

March 10, 2015

Funding Presenters:

  • Impact Product Development, which has developed a device that turns a smartphone into a mobile fish scale for bass and other fishing tournaments; and
  • Sober Grid, which is building a social networking app that allows recovering alcoholics to connect to share healthy interactions among a confidential community of like minded persons.
Posted in Past Beacon Meetings | Tagged , , , , | Leave a comment